Skip to content

Myeloperoxidase Antibody Screening by Line Blot

Published: August 9, 2026Updated: August 16, 2026

This test detects antibodies related to myeloperoxidase, an enzyme found in white blood cells. It may help identify certain autoimmune conditions or connective tissue disorders.

Quick summary

["This screening helps assess potential autoimmune reactions involving white blood cells."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
89507-8
Short code
Myeloperoxidase Ab Ser Ql Line blot
Synonyms
Myeloperoxidase Ab Ser Ql Line blot
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
line-blot
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What Is This Test Measuring?

Myeloperoxidase (MPO) is an enzyme produced by certain white blood cells (neutrophils). Antibodies against MPO can be part of an autoimmune response, where the immune system mistakenly attacks healthy cells. This test checks for the presence of these antibodies in your blood.

Why Might You Need This Test?

Your healthcare provider may order this test if you have symptoms like joint pain, skin rashes, or other signs of autoimmune diseases. It may also be used to monitor conditions like systemic lupus erythematosus (SLE) or other connective tissue disorders.

How Is the Test Performed?

A blood sample is drawn from a vein in your arm. The sample is then tested using a line blot assay, which detects specific antibodies against myeloperoxidase. Results are qualitative (positive or negative) rather than a numeric value.

What Are Possible Results?

A positive result means antibodies against myeloperoxidase were found. A negative result indicates no detectable antibodies. Interpretation depends on clinical context and may require further testing.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Positive results may suggest an autoimmune condition affecting white blood cells or connective tissues. However, false positives can occur, so results should be evaluated alongside other symptoms, medical history, and tests. Consult your doctor for guidance.

Short name

Myeloperoxidase Antibody (Screen)

Frequently asked questions

What does a positive result mean?
A positive result indicates the presence of antibodies against myeloperoxidase, which may signal an autoimmune reaction. This could be linked to conditions like lupus or other connective tissue disorders, but further evaluation is needed to confirm a diagnosis.
Will I need more tests if this result is positive?
Yes, additional tests may be recommended to determine the cause of your symptoms. Your doctor might order further blood tests, imaging, or a detailed medical evaluation to guide treatment options.
How long does it take to get results?
Results are typically available within 1 to 3 business days, depending on lab processing times. Your healthcare provider will discuss the findings with you during your follow-up visit.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy